MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Finance & Investment / Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.
Old Articles: <Older 51841-51850 Newer>
The Motley Fool
September 9, 2011
Dari FitzGerald
3 Risks Zipcar Investors Need to Watch Zipcar's investors need to worry about these findings in the company's 10-K report. mark for My Articles 47 similar articles
The Motley Fool
September 9, 2011
Evan Niu
One Medical-Device Stock I Just Bought There have been 8,656 MAKOplasty procedures already performed and the global opportunities are just beginning. mark for My Articles 54 similar articles
The Motley Fool
September 9, 2011
Shubh Datta
Genesco Dashes Ahead The shoe retailer narrows losses as revenues soar. mark for My Articles 20 similar articles
The Motley Fool
September 9, 2011
Harsh Chauhan
How Long Will Acquisition Costs Hurt Atlantic Tele? Acquisition costs pull down the Telecommunications provider's quarterly earnings. mark for My Articles 73 similar articles
The Motley Fool
September 9, 2011
Rich Smith
Who Wants to Buy Travelzoo? ChaPaVe Partners, the previously unheard of firm, announces a "tactical tender offer" for 1.5 million shares of Travelzoo. mark for My Articles 35 similar articles
The Motley Fool
September 9, 2011
Steve Rosenbush
This Stock Is Seeing a Stampede in Aisle 2 The ever-changing inventory at Ross Stores keeps discount shoppers engaged. mark for My Articles 159 similar articles
The Motley Fool
September 9, 2011
Matt Koppenheffer
China Green Agriculture Shares Popped: What You Need to Know Shares of Chinese fertilizer producer China Green Agriculture were growing like weeds, gaining as much as 23% in intraday trading after a strong earnings report. mark for My Articles 137 similar articles
The Motley Fool
September 9, 2011
Anders Bylund
What's Wrong With VeriSign? The management turnstile clicks again, dashing hopes of a buyout -- or a stable executive team. mark for My Articles 16 similar articles
The Motley Fool
September 9, 2011
Frank Vinluan
GSK Halts Part of Breast Cancer Trial; Drug Can't Top Herceptin GlaxoSmithKline has halted part of a phase 3 breast cancer clinical study after an independent committee concluded that the GSK drug administered alone is unlikely to work better than a rival cancer drug from Roche. mark for My Articles 310 similar articles
The Motley Fool
September 9, 2011
Harsh Chauhan
Can Anadigics Rebound After a Bad Quarter? Anadigics reports a weak second quarter. mark for My Articles 206 similar articles
<Older 51841-51850 Newer>    Return to current articles.